What exactly did UBS change on March 16, 2026?

UBS maintained a Neutral rating on Petco and raised its price target to **$4** on March 16, 2026. The firm signaled modest upside but no clear buy recommendation.

How should I interpret the WOOF analyst rating for investing?

A Neutral WOOF analyst rating means UBS sees the stock trading near fair value. Investors should combine this with fundamentals and sector checks before making decisions.

Did the market move after the UBS note and what is the market cap?

The note coincided with a reported **-2.87% ($-0.10)** price move since the update. Market cap is **$953,417,533**, reflecting small-cap sensitivity to analyst notes.

What is Meyka AI’s view on WOOF overall?

Meyka AI rates WOOF with a grade of **B**. This grade considers benchmark comparison, sector performance, growth metrics, and analyst consensus, but it is not financial advice.

Analyst Ratings

UBS Maintains Neutral on Petco Health & Wellness Co., Inc. (WOOF) Mar 16, 2026

ByDanny Kontos March 17, 2026March 17, 2026

On March 16, 2026 UBS maintained a Neutral rating on Petco Health and Wellness Company, Inc. and raised its price target to $4, the main development in the WOOF analyst rating today. UBS kept Neutral while nudging its outlook higher on valuation or recovery prospects. The update came through StreetInsider and was also picked up by Benzinga. Meyka AI rates WOOF with a grade of B. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.